-
Basel, September 30, 2021 — At its eighth annual ESG investor event hosted today, Novartis shared progress against its Environmental, Social and Governance (ESG) targets and updated on its most material ESG topics, including access to medicines, patient health and safety, innovation and ethical standards.Sustainable DevelopmentSocial CommitmentNovartis AccessAccess to Healthcare
-
Basel, November 19, 2020 — Novartis today announced the signature of five virtual power purchase agreements (VPPAs), which are expected to collectively add more than 275 megawatts of clean power to the electrical grid. This move makes Novartis the first pharmaceutical company set to achieve 100% renewable electricity in its European operations…Sustainable DevelopmentSocial CommitmentReimagine MedicineFuture of Healthcare
-
Healthy Family program combines health education with improved access to doctors and medicines.
Access to HealthcareLocal ImpactNovartis Social BusinessSocial CommitmentSustainable Development -
Today, many companies are trying to solve global health challenges through philanthropy. However, it has become clear that philanthropy alone is no longer enough to make a lasting impact.
Access to HealthcareFuture of HealthcareGlobal Health PartnershipsNovartis Social BusinessSustainable Development -
Working with a nonprofit, Novartis is helping train healthcare workers to diagnose and treat chronic ailments such as diabetes.
Access to HealthcareAfricaGlobal Health PartnershipsSustainable DevelopmentDiabetes